IP Library Assignment 022299/0730
Patent Assignment
Reel/Frame 022299/0730

Assignment of Assignor's Interest

Recorded: 2009-02-24 Pages: 2
Assignor
MILLENNIUM PHARMACEUTICALS, INC.
Executed: 2009-02-24
Assignee
BAYER SCHERING PHARMA AG
MULLERSTRASSE 178, BERLIN, 13353, GERMANY
Covered Properties (3)
Twik-5 Potassium Channel Nucleic Acids and Uses Thereof
Patent: 6,670,149 →
Application: 09/431,367 →
Novel Potassium Channel Molecules and Uses Therefor
Patent: 6,664,373 →
Application: 09/561,763 →
Novel Potassium Channel Molecules and Uses Therefor
Patent: 7,517,659 →
Application: 10/701,013 →
Publication: US 2004/0063179
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 1, 1999
From: CURTIS, RORY A.J.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 010363/0220 →
Assignment of Assignor's Interest Jan 9, 2001
From: CURTIS, RORY A. J.; SILOS-SANTIAGO, INMACULADA
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 011438/0336 →
Assignment of Assignor's Interest Jul 13, 2011
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 026586/0312 →